NCT03573674 (SujuKE) is a NA clinical trial of CE - Cognitive Ergonomics (KERGO) in Ergonomics, sponsored by Finnish Institute of Occupational Health.

Who is sponsoring NCT03573674?

NCT03573674 is sponsored by Finnish Institute of Occupational Health.

What drugs are being tested in NCT03573674?

Interventions in NCT03573674: CE - Cognitive Ergonomics (KERGO), RS - Recovery Support (KUORMA).

What condition does NCT03573674 study?

NCT03573674 studies Ergonomics.

Is NCT03573674 still recruiting?

NCT03573674 is currently completed. Last updated 6 April 2020.

Last reviewed 2020-04-06 · How we verify

NCT03573674: SujuKE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Work Flow Through Cognitive Ergonomics. An Intervention Study

Completed NA Last updated 6 April 2020

What this trial tests

NA trial testing CE - Cognitive Ergonomics (KERGO) in Ergonomics in 927 participants. Completed in 31 October 2019.

Timeline

1 November 2017

Primary endpoint
31 October 2019

31 October 2019

Quick facts

Lead sponsor	Finnish Institute of Occupational Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	927
Start date	1 November 2017
Primary completion	31 October 2019
Estimated completion	31 October 2019
Sites	1 location across Finland

Drugs / interventions tested

CE - Cognitive Ergonomics (KERGO)
RS - Recovery Support (KUORMA)

Conditions studied

Ergonomics — all drugs for Ergonomics →

Sponsor

Finnish Institute of Occupational Health

Who can join

Adults 18 to 70, any sex, with Ergonomics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the SujuKE study is to test the effectiveness of workplace cognitive ergonomics development program designed to decrease cognitively disrupting work conditions and work-related cognitive stress, and to improve work flow. The cognitive ergonomics workplace intervention includes cognitive ergonomics workshop, work experiments, and intervention task questionnaires. Its effect on changes in subjective measures of work conditions, work flow, stress, and work productivity will be studied. The hypothesis is that cognitive ergonomics intervention decreases the level of cognitive strain related to work conditions, and this change is associated with higher level in work flow, well-being, and productivity at work.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of a cognitive ergonomics workplace intervention (CogErg) on cognitive strain and well-being: a cluster-randomized controlled trial. A study protocol.
Kalakoski V, Selinheimo S, Valtonen T, Turunen J, et al · · 2020 · cited 19× · PMID 31898551 · DOI 10.1186/s40359-019-0349-1

Verify or expand the search:

Other recruiting trials for Ergonomics

Currently open trials in the same condition.

NCT07324655 — Association Between Office Ergonomics, Work Organization, and Musculoskeletal Complaints in Medical Secretaries · recruiting

Other Finnish Institute of Occupational Health trials

Trials by the same sponsor.

NCT06827626 — Tailored Treatment of Insomnia in Social and Health Care Sector Shift Workers in Occupational Health Care · NA · active not recruiting
NCT06709898 — Stroke in Working Age and Job Accommodation in Facilitating Transition Back to Work · NA · recruiting
NCT04532827 — Web-based Rehabilitation for Persistent Physical Symptoms. · NA · unknown
NCT03648593 — Promo@Work Entrepreneurs · NA · unknown
NCT03854877 — DagisWork-a Workplace Health Behaviour E-intervention · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03573674 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Finnish Institute of Occupational Health
Last refreshed: 6 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03573674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing